systems, including NanoKnife Ablation Systems. It designs, develops, manufactures and markets a line of therapeutic and diagnostic devices that enable interventional physicians (interventional radiologists, vascular surgeons, surgical oncologists and others) to treat PVD, tumors, and other non-coronary diseases. The Company’s segments include Vascular segment, which is responsible for products targeting the venous intervention, dialysis access, thrombus management and peripheral disease markets, and Oncology /Surgery segment, is responsible for radio frequency (RF) Ablation, embolization, Habib and NanoKnife product lines.